|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 336.80 SEK | -1.35% |
|
-1.91% | +2.04% |
| 04:09pm | Sobi 2025 revenue, EBITA margin exceed outlook | RE |
| 04:00pm | Strong Sales Prompt Sobi to Issue Positive Profit Warning for 2025 (Update 2) | FW |
| Capitalization | 118B 12.81B 10.99B 10.23B 9.52B 17.77B 1,156B 19.16B 46.29B 553B 48.04B 47.05B 2,027B | P/E ratio 2025 * |
-676x | P/E ratio 2026 * | 20x |
|---|---|---|---|---|---|
| Enterprise value | 128B 13.91B 11.93B 11.11B 10.34B 19.3B 1,256B 20.8B 50.26B 601B 52.16B 51.08B 2,201B | EV / Sales 2025 * |
4.46x | EV / Sales 2026 * | 3.87x |
| Free-Float |
51.66% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Swedish Orphan Biovitrum AB
| 1 day | -1.32% | ||
| 1 week | -1.91% | ||
| Current month | +2.04% | ||
| 1 month | +4.81% | ||
| 3 months | +12.82% | ||
| 6 months | +15.43% | ||
| Current year | +2.04% |
| 1 week | 327.8 |  | 360.6 |
| 1 month | 314.4 | | 360.6 |
| Current year | 327.8 | | 360.6 |
| 1 year | 241.8 | | 360.6 |
| 3 years | 197.9 | | 360.6 |
| 5 years | 127.1 | | 360.6 |
| 10 years | 89.5 | | 360.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Guido Oelkers
CEO | Chief Executive Officer | 61 | 22/05/2017 |
Henrik Stenqvist
DFI | Director of Finance/CFO | 59 | 20/07/2018 |
| Chief Tech/Sci/R&D Officer | 55 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Staffan Schüberg
BRD | Director/Board Member | 57 | 01/01/2020 |
| Director/Board Member | 70 | 01/01/2021 | |
Filippa Stenberg
BRD | Director/Board Member | - | - |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +3.92% | 1.15% | 285 M€ | |
| +1.20% | 0.9% | 4 M€ | |
| -.--% | 0.48% | 0 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.35% | -1.91% | +5.66% | +46.32% | 12.81B | |
| -0.60% | -6.31% | +6.68% | +3.07% | 77.37B | |
| +1.97% | +96.50% | +96.50% | +96.50% | 60.9B | |
| -0.42% | +2.38% | +35.84% | +218.66% | 57.48B | |
| +1.03% | +3.11% | -37.32% | -38.06% | 55.92B | |
| -0.96% | -9.81% | +18.97% | -42.08% | 24.84B | |
| -1.04% | -0.25% | +45.80% | +30.01% | 20.8B | |
| -0.50% | -0.06% | +156.85% | +111.15% | 19.9B | |
| +0.75% | -0.11% | +53.01% | +1,234.75% | 17.05B | |
| -2.92% | +16.48% | +13.43% | -79.32% | 15.86B | |
| Average | -0.41% | -0.60% | +39.54% | +158.10% | 36.29B | |
| Weighted average by Cap. | -0.00% | -0.84% | +33.34% | +106.73% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 28.62B 3.12B 2.67B 2.49B 2.32B 4.32B 281B 4.66B 11.26B 135B 11.68B 11.44B 493B | 31.56B 3.44B 2.95B 2.74B 2.55B 4.77B 310B 5.14B 12.42B 148B 12.88B 12.62B 544B |
| Net income | -253M -27.49M -23.59M -21.96M -20.44M -38.14M -2.48B -41.12M -99.34M -1.19B -103M -101M -4.35B | 5.71B 621M 533M 496M 462M 862M 56.08B 929M 2.24B 26.83B 2.33B 2.28B 98.3B |
| Net Debt | 10.09B 1.1B 942M 877M 816M 1.52B 99.12B 1.64B 3.97B 47.42B 4.12B 4.03B 174B | 4.46B 485M 416M 388M 361M 673M 43.79B 725M 1.75B 20.95B 1.82B 1.78B 76.75B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/01/26 | 339.40 kr | -0.59% | 979,803 |
| 14/01/26 | 341.40 kr | +1.73% | 627,977 |
| 13/01/26 | 335.60 kr | +0.54% | 478,261 |
| 12/01/26 | 333.80 kr | -4.03% | 574,465 |
| 09/01/26 | 347.80 kr | +0.46% | 429,304 |
Delayed Quote Nasdaq Stockholm, January 15, 2026 at 07:01 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SOBI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition